Those with progressive multiple sclerosis are reported to have a larger number of circulating LILRB1+ CD8+ T lymphocytes and LILRB1+ natural killer cells in comparison to patients with relapsing-remitting multiple sclerosis (Storm et al., 2021). The gene discussed is LILRB1; the disease is relapsing-remitting multiple sclerosis.